Several proven treatments can shrink tumors in dogs, ranging from injectable drugs that destroy tumors in a single dose to chemotherapy, radiation, targeted oral medications, and steroids. The best option depends on the type of tumor, its location, and how far it has progressed. Here’s what each approach does and which cancers it works for.
Injectable Treatments That Destroy Tumors Directly
One of the most notable developments in canine oncology is an injectable drug called tigilanol tiglate, sold under the brand name Stelfonta. It’s injected directly into the tumor and works by breaking down the tumor tissue and cutting off its blood supply. In clinical use, 75% of dogs with mast cell tumors achieved a complete response after just one injection, assessed one month after treatment. The tumor essentially breaks apart and is shed from the body over the following weeks, leaving a wound that heals on its own.
This option works specifically for non-spreadable mast cell tumors located on or just under the skin. It’s not a fit for every cancer type, but for eligible dogs it avoids the need for surgery or prolonged treatment courses. Your veterinarian can assess whether the tumor’s size and location make it a candidate.
Chemotherapy for Widespread or Aggressive Cancers
Chemotherapy remains one of the most common ways to shrink tumors in dogs, especially when cancer has spread or when surgery isn’t possible. The drugs fall into several classes, but they all work by interfering with cancer cells’ ability to divide and survive. Platinum-based drugs like carboplatin are widely used in veterinary medicine. They work by forming crosslinks in a cancer cell’s DNA, which prevents it from copying itself and ultimately triggers cell death.
Dogs generally tolerate chemotherapy better than humans do. Veterinary oncologists use lower doses relative to body size, so severe side effects like hair loss and prolonged nausea are less common. Some dogs experience a few days of reduced appetite or mild digestive upset after a session, but most bounce back quickly. Treatment is typically given in cycles, with sessions spaced one to three weeks apart depending on the protocol.
Targeted Drugs That Block Tumor Growth Signals
Some canine cancers are driven by a specific molecular glitch: a mutation in a gene called c-KIT that tells cells to keep growing nonstop. Targeted drugs called tyrosine kinase inhibitors (TKIs) block that signal. Two TKIs are used in dogs: toceranib (brand name Palladia) and masitinib. Rather than killing all rapidly dividing cells the way traditional chemo does, these drugs zero in on the faulty growth signal.
TKIs work through multiple mechanisms at once. They trigger programmed cell death in cancer cells, freeze cells in a resting phase so they stop multiplying, and reduce the tumor’s ability to build new blood vessels to feed itself. In lab studies on canine mammary tumor cells, masitinib produced a dose-dependent drop in a key blood-vessel growth factor called VEGF, essentially starving the tumor of nutrients.
Mast cell tumors are the primary target for TKIs in dogs, and masitinib is approved in Europe specifically for that use. Research is also exploring their effectiveness in mammary tumors, since many malignant mammary tumors in dogs express the same c-KIT target. These are oral medications given at home, which makes them more convenient than IV chemotherapy, though they require regular blood work to monitor for side effects like digestive issues or changes in protein levels.
Steroids for Fast Lymphoma Response
Prednisone and related corticosteroids are among the most frequently used drugs in canine cancer care, and they can produce dramatic results in one specific cancer: lymphoma. In dogs with lymphoma, prednisone triggers rapid programmed death of the cancerous lymphoid cells. Swollen lymph nodes can shrink noticeably within days, and dogs often feel significantly better almost immediately.
Steroids alone aren’t a long-term solution. The response typically lasts weeks to a couple of months before the cancer adapts. That’s why veterinary oncologists usually use prednisone as part of a multi-drug chemotherapy protocol rather than as a standalone treatment. Still, when a dog is visibly uncomfortable from enlarged lymph nodes or related symptoms, prednisone provides fast relief while a fuller treatment plan gets underway.
Radiation Therapy
Radiation works by damaging the DNA inside tumor cells so they can no longer divide. It’s most often used for tumors that can’t be fully removed with surgery, or to shrink a tumor before surgery makes it operable. Two main approaches exist: definitive radiation, which uses many small doses over several weeks to maximize tumor kill, and palliative radiation, which uses fewer, larger doses aimed at relieving pain and slowing growth.
A newer technique called stereotactic body radiotherapy delivers highly focused beams to the tumor in just one to three sessions. In a study of dogs with soft tissue sarcomas treated this way, about 30% had a measurable response, including some complete responses where the tumor disappeared entirely. Dogs that responded lived significantly longer, with a median survival of 475 days compared to 201 days for non-responders. Radiation does require general anesthesia for each session since the dog must stay perfectly still, but the sessions themselves are painless.
Low-Dose Metronomic Chemotherapy
This approach flips traditional chemotherapy on its head. Instead of hitting the body with high doses at intervals, metronomic chemotherapy uses low doses of oral medication given daily or every other day without breaks. The goal isn’t to kill cancer cells directly. Instead, the low doses target the blood vessels that feed the tumor.
Tumors can’t grow beyond a tiny size without building new blood vessels to supply themselves with oxygen and nutrients. Metronomic chemo disrupts this process by lowering blood-vessel growth factors and raising natural proteins that suppress new vessel formation. Over time, the tumor’s blood supply shrinks and the tumor follows. The doses are kept low enough to avoid the bone marrow suppression that comes with standard chemo, which means fewer side effects and a better quality of life during treatment. This approach is becoming a mainstream option in veterinary oncology, often used after surgery to slow recurrence or as a gentler alternative for older dogs.
What About Diet?
You’ll find claims online that specific diets can shrink tumors in dogs. The most studied is the ketogenic diet, which is very high in fat and very low in carbohydrates. The theory is that cancer cells rely heavily on sugar for fuel, so starving them of carbohydrates could slow their growth.
A large review of animal studies found that ketogenic diets did reduce tumor weight and volume on average, and animals on the diet lived longer. A fat-to-carbohydrate ratio of 4:1 seemed to produce the strongest survival benefit. However, nearly all of this research was conducted in lab mice, not dogs. No randomized controlled trials in dogs exist, and the available evidence in any species comes mostly from case reports and small pilot studies. A high-fat, low-carb diet might support overall health in a dog with cancer since cancer can cause muscle wasting, but there’s no reliable clinical evidence that diet alone will shrink a tumor in your dog.
Choosing the Right Approach
The treatment most likely to shrink your dog’s tumor depends heavily on what kind of tumor it is. Mast cell tumors on the skin may respond to a single injection of tigilanol tiglate or to targeted TKI drugs. Lymphoma often responds quickly to steroids and multi-drug chemotherapy. Soft tissue sarcomas and tumors in hard-to-reach locations may be best served by radiation. Many dogs benefit from a combination of approaches, such as surgery followed by metronomic chemo to prevent regrowth.
A veterinary oncologist can run tests to identify the tumor type and check for specific mutations (like c-KIT) that predict which targeted therapies will work. Staging tests, including bloodwork and imaging, help determine whether the cancer has spread, which shapes the treatment plan. Age, overall health, and how your dog handles treatment all factor into the decision as well.